SEC Tracker
Get the app
VERU · XBRL financial data

Veru financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (VERU's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue3,862*2,1414,135—————————
Revenue from contracts with customers3,862*2,1414,1353,9546,657*—00————
Cost of goods and services sold2,321*9903,4572,6163,969*———————
Gross profit1,541*1,1506781,3382,687*———————
Research and development6,668*1,6502,9874,8793,292*5,7173,9323,0212,919*1,3443,1464,353
Selling, general and administrative6,775*8,3017,5807,5087,795*5,2275,1645,011————
General and administrative————year only5,2275,1645,0114,541*4,0804,0733,361
Total operating expenses13,443*9,95110,56712,38711,087*10,9449,0978,0317,459*5,4247,2197,714
Operating income (loss)(10,901)*(7,883)(9,889)(10,939)(8,205)*(10,249)(8,122)(7,546)1,167*(5,424)(7,219)(7,714)
Interest expense207*165145127170*———————
Other income (expense)165*81361294125*163270223112*212195179
Income tax expense (benefit)557*(72)182162453*0000*000
Net income (loss)(10,857)*(8,276)(10,026)(10,969)(8,531)*(8,945)(7,902)(7,333)1,454*(5,333)(2,741)(6,988)
Earnings per share, basic USD per share(0.12)*(0.08)(0.07)(0.07)(0.06)*(0.06)(0.05)(0.50)—(0.26)(0.12)(0.30)
Earnings per share, diluted USD per share(0.12)*(0.08)(0.07)—————————
Weighted average shares, basic thousands of shares90,180*100,602146,381146,383146,384*146,384146,38614,658—20,31123,05023,050
Weighted average shares, diluted thousands of shares90,180*100,602146,381—————————
  • † Share count changed about 1/10 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (VERU's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents9,625——29,15124,91626,60720,01815,01015,79532,99127,59723,880
Accounts receivable4,5072,3832,7851,6423,960———————
Inventory6,6976,9124,8054,9424,144———————
Prepaid and other current assets1,0982,2421,8851,6151,7831,7731,3591,1835951,4102,5911,437
Total current assets22,93353,34545,13738,47635,22328,38021,37816,19318,91536,80733,35527,228
Property and equipment, net1,6531,5601,5341,4911,285452423393365337308280
Right-of-use asset4,3324,1343,9473,7573,5623,1283,0032,8762,7462,6142,4792,342
Goodwill6,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,879
Total assets50,02380,56771,80064,63260,41939,82932,67227,33129,83647,56743,08337,028
Accounts payable12,93110,5182,4643,0183,0371,9952,2052,5393,1211,5162,0721,710
Total current liabilities17,81116,6259,56610,62011,8686,3485,6196,6827,7857,1285,3896,156
Lease liability, non-current3,6343,4563,2633,0752,9212,7752,6412,5012,3582,2132,0631,908
Total liabilities30,34528,96526,59127,01128,10213,20211,62511,98611,50310,4438,2978,651
Accumulated deficit(256,768)(265,044)(275,070)(286,039)(294,570)(303,515)(311,417)(318,749)(317,296)(322,628)(325,370)(332,358)
Total stockholders' equity19,67851,60245,21037,62032,31726,62721,04715,34518,33337,12434,78628,376
Total liabilities and equity50,02380,56771,80064,63260,41939,82932,67227,33129,83647,56743,08337,028
Common shares outstanding (cover page) thousands of shares93,673146,381146,384146,384146,384146,384146,58414,65016,05016,05016,05017,050
  • † Share count changed about 1/10 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (VERU's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(10,857)*(8,276)(10,026)(10,969)(8,531)*(8,945)(7,902)(7,333)1,454*(5,333)(2,741)(6,988)
Stock-based compensation4,685*3,4073,634*3,376*3,227*2,6742,224*1,669*1,535*758403*578*
Depreciation and amortization70*7266*65*65*6529*29*29*2828*28*
Net cash from operating activities(9,492)*(6,020)(5,650)*(5,646)*(4,366)*(11,333)(7,736)*(5,482)*(5,491)*(6,169)(8,915)*(5,467)*
Purchases of property and equipment213*041*55*63*10*0*0*00*0*
Net cash from investing activities787*0(41)*55*132*17,2451,148*474*6,276*03,520*1,802*
Net cash from financing activities2,118*36,974(150)*3*0*(4,222)0*0*0*23,3660*(52)*
Net change in cash(6,588)*30,954(5,841)*(5,587)*(4,235)*1,691(6,589)*(5,008)*784*17,197(5,395)*(3,717)*
  • † Share count changed about 1/10 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Veru23,880not reported(5,467)*17.1M4.4 quarters 10-QJun 30, 2026
Lifevantage14,92042,377*4,767*12.5M— 10-KJun 30, 2026
Whitehawk Therapeutics85,2340(14,529)*57.0M13.1 quarters 10-QJun 30, 2026
Medicinova25,416458(1,920)*49.2M13.2 quarters 10-QJun 30, 2026
Corbus Pharmaceuticals Holdings23,370not reported(29,626)*19.3M4.0 quarters 10-QJun 30, 2026
PDS Biotechnology5,596not reported(2,793)*56.0M2.0 quarters 10-QJun 30, 2026
Sutro Biopharma54,3359,839(38,290)*16.6M4.3 quarters 10-QJun 30, 2026
iBio56,3950*(6,228)*64.3M14.1 quarters 10-KJun 30, 2026
Seres Therapeutics15,594736(22,394)*9.9M0.7 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.